Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-14-006748
Filing Date
2014-08-07
Accepted
2014-08-07 16:06:58
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2220922z10-q.htm 10-Q 450319
2 EX-31.1 a2220922zex-31_1.htm EX-31.1 11699
3 EX-31.2 a2220922zex-31_2.htm EX-31.2 11675
4 EX-32.1 a2220922zex-32_1.htm EX-32.1 6104
5 EX-32.2 a2220922zex-32_2.htm EX-32.2 6082
6 EX-99.1 a2220922zex-99_1.htm EX-99.1 100004
13 G168664MM01I001.JPG g168664mm01i001.jpg GRAPHIC 2041
  Complete submission text file 0001047469-14-006748.txt   5719185

Data Files

Seq Description Document Type Size
7 EX-101.INS vstm-20140630.xml EX-101.INS 646200
8 EX-101.SCH vstm-20140630.xsd EX-101.SCH 76508
9 EX-101.CAL vstm-20140630_cal.xml EX-101.CAL 56402
10 EX-101.DEF vstm-20140630_def.xml EX-101.DEF 340853
11 EX-101.LAB vstm-20140630_lab.xml EX-101.LAB 1147315
12 EX-101.PRE vstm-20140630_pre.xml EX-101.PRE 551442
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 141023893
SIC: 2834 Pharmaceutical Preparations